Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nasathera CPM - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Nasathera CPM

Approved

STANDARD

Nasathera CPM

Morishita-Seggs Pharmaceuticals, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 506cd9d1a8a93698
Company: Morishita-Seggs Pharmaceuticals, Inc.
Type: Standard

Approval Details

Approval Id: 506cd9d1a8a93698
Drug Approval Philippines Name: Nasathera CPM
Product Name: Nasathera CPM
Registration Number: DR-XY36065
Brand Name: Nasathera CPM
Generic Name: Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
Dosage Form: Syrup
Dosage Strength: 12.5mg/2mg/5mL
Manufacturer: Morishita-Seggs Pharmaceuticals, Inc.
Distributor: Oxford Distributions, Inc.
Issuance Date: 31 May 2024
Expiry Date: 25 June 2029
Pharmacologic Category: Nasal Decongestant / Antihistamine
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

506cd9d1a8a93698

Type

Standard

Back to Philippines FDA Approvals